Gary Taylor
Stock Analyst at TD Cowen
(1.97)
# 3,139
Out of 5,139 analysts
148
Total ratings
50.51%
Success rate
-0.43%
Average return
Main Sectors:
Stocks Rated by Gary Taylor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company | Maintains: Buy | $44 → $25 | $11.68 | +114.04% | 5 | Aug 7, 2025 | |
| BBWI Bath & Body Works | Maintains: Buy | $40 → $42 | $23.27 | +80.49% | 2 | Nov 26, 2024 | |
| PIII P3 Health Partners | Maintains: Hold | $45 → $13 | $3.20 | +290.63% | 2 | Nov 20, 2024 | |
| AGL agilon health | Maintains: Hold | $6 → $2 | $1.02 | +96.08% | 4 | Nov 11, 2024 | |
| HUM Humana | Maintains: Hold | $261 → $268 | $273.28 | -1.93% | 20 | Nov 4, 2024 | |
| ALHC Alignment Healthcare | Maintains: Buy | $10 → $13 | $22.50 | -42.22% | 6 | Oct 31, 2024 | |
| HCA HCA Healthcare | Maintains: Buy | $450 → $440 | $469.29 | -6.24% | 9 | Oct 28, 2024 | |
| UNH UnitedHealth Group | Maintains: Buy | $601 → $609 | $331.02 | +83.98% | 4 | Oct 18, 2024 | |
| CNC Centene | Maintains: Buy | $80 → $89 | $45.75 | +94.54% | 10 | Jul 31, 2024 | |
| MOH Molina Healthcare | Maintains: Buy | $351 → $378 | $191.40 | +97.49% | 18 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $183 → $220 | $199.88 | +10.07% | 12 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $139 → $150 | $104.74 | +43.21% | 11 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $30 → $26 | $23.33 | +11.44% | 5 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $39 → $35 | $15.90 | +120.13% | 2 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $564 → $585 | $374.87 | +56.05% | 2 | Jul 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $3 → $6 | $16.55 | -63.75% | 1 | Feb 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $10 → $8 | $7.25 | +10.34% | 3 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $242 → $329 | $272.21 | +20.86% | 3 | May 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | $7 → $3 | $2.54 | +18.11% | 4 | Feb 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $17 | $5.85 | +190.60% | 1 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $28 → $20 | $196.74 | -89.83% | 12 | Sep 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $33 → $20 | $21.86 | -8.51% | 6 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $3.20 | - | 6 | Dec 14, 2017 |
Acadia Healthcare Company
Aug 7, 2025
Maintains: Buy
Price Target: $44 → $25
Current: $11.68
Upside: +114.04%
Bath & Body Works
Nov 26, 2024
Maintains: Buy
Price Target: $40 → $42
Current: $23.27
Upside: +80.49%
P3 Health Partners
Nov 20, 2024
Maintains: Hold
Price Target: $45 → $13
Current: $3.20
Upside: +290.63%
agilon health
Nov 11, 2024
Maintains: Hold
Price Target: $6 → $2
Current: $1.02
Upside: +96.08%
Humana
Nov 4, 2024
Maintains: Hold
Price Target: $261 → $268
Current: $273.28
Upside: -1.93%
Alignment Healthcare
Oct 31, 2024
Maintains: Buy
Price Target: $10 → $13
Current: $22.50
Upside: -42.22%
HCA Healthcare
Oct 28, 2024
Maintains: Buy
Price Target: $450 → $440
Current: $469.29
Upside: -6.24%
UnitedHealth Group
Oct 18, 2024
Maintains: Buy
Price Target: $601 → $609
Current: $331.02
Upside: +83.98%
Centene
Jul 31, 2024
Maintains: Buy
Price Target: $80 → $89
Current: $45.75
Upside: +94.54%
Molina Healthcare
Jul 29, 2024
Maintains: Buy
Price Target: $351 → $378
Current: $191.40
Upside: +97.49%
Jul 26, 2024
Maintains: Hold
Price Target: $183 → $220
Current: $199.88
Upside: +10.07%
Jul 24, 2024
Maintains: Hold
Price Target: $139 → $150
Current: $104.74
Upside: +43.21%
Mar 1, 2024
Maintains: Outperform
Price Target: $30 → $26
Current: $23.33
Upside: +11.44%
Nov 14, 2023
Upgrades: Outperform
Price Target: $39 → $35
Current: $15.90
Upside: +120.13%
Jul 24, 2023
Maintains: Outperform
Price Target: $564 → $585
Current: $374.87
Upside: +56.05%
Feb 14, 2023
Maintains: Market Perform
Price Target: $3 → $6
Current: $16.55
Upside: -63.75%
Nov 14, 2022
Maintains: Outperform
Price Target: $10 → $8
Current: $7.25
Upside: +10.34%
May 9, 2022
Upgrades: Outperform
Price Target: $242 → $329
Current: $272.21
Upside: +20.86%
Feb 2, 2022
Upgrades: Market Perform
Price Target: $7 → $3
Current: $2.54
Upside: +18.11%
Sep 10, 2021
Initiates: Market Perform
Price Target: $17
Current: $5.85
Upside: +190.60%
Sep 21, 2020
Downgrades: Underweight
Price Target: $28 → $20
Current: $196.74
Upside: -89.83%
Feb 24, 2020
Maintains: Neutral
Price Target: $33 → $20
Current: $21.86
Upside: -8.51%
Dec 14, 2017
Downgrades: Underweight
Price Target: n/a
Current: $3.20
Upside: -